Ebastine in chronic urticaria: A double-blind placebo-controlled study
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 2 (2) , 51-53
- https://doi.org/10.3109/09546639109086774
Abstract
The effect of ebastine 10 mg once daily was studied in a double-blind comparison with placebo in 204 patients with chronic urticaria. Symptom severity, as assessed by both investigator and patient, was significantly reduced by ebastine after 7 and 14 days of treatment. The drug was well tolerated in the majority of patients, with the overall incidence of side-effects not significantly different to that of placebo. It is concluded that ebastine represents an effective and well-tolerated alternative to other non-sedating antihis-tamines in the treatment of chronic urticaria.Keywords
This publication has 7 references indexed in Scilit:
- A double‐blind placebo‐controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patientsJournal of Internal Medicine, 1989
- Efficacy and Tolerability of Ebastine at Two Dose Levels in the Treatment of Seasonal Allergic RhinitisClinical Drug Investigation, 1989
- Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.British Journal of Clinical Pharmacology, 1988
- The pharmacokinetics, antihistamine and concentration‐effect relationship of ebastine in healthy subjects.British Journal of Clinical Pharmacology, 1988
- The Urticarias Current Concepts in Pathogenesis and TreatmentDrugs, 1985
- AstemizoleDrugs, 1984
- Mechanism of action of antipruritic drugs.BMJ, 1983